Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
Saved in:
| Title: | Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder. |
|---|---|
| Authors: | De Candia MP (AUTHOR), Di Sciascio G (AUTHOR), Durbano F (AUTHOR), Mencacci C (AUTHOR), Rubiera M (AUTHOR), Aguglia E (AUTHOR), Garavini A (AUTHOR), Bersani G (AUTHOR), Di Sotto A (AUTHOR), Placidi G (AUTHOR), Cesana BM (AUTHOR) |
| Source: | Clinical Therapeutics. Dec2009, Vol. 31 Issue 12, p2851-2859. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
